Gonadotropin-releasing hormone analogs (“puberty blockers”) have rapidly become the preferred method of treatment for childhood gender nonconformity or for teenagers experiencing various levels of gender dysphoria. Use of these drugs raises questions regarding the ability of prepubescent children to give an informed consent to life-altering interventions with unknown future effects. The article argues the use of puberty blockers fails to meet the standard of informed consent.